TruMED, founded in 2019 and based in Southlake, USA, is an AI-driven company specializing in digital therapeutics. The company's core mission is to bridge the gap between bariatric patients and healthcare providers by leveraging technology to deliver data, analysis, and support. TruMED offers a comprehensive bariatric care solution that includes tools, information, and interventions aimed at achieving positive long-term outcomes for patients. Their market focus is on addressing the obesity epidemic through innovative remote patient monitoring and personalized care.
Notable affiliated people and investors include experts in healthcare technology and AI, though specific names are not provided. Key achievements of TruMED include the successful implementation of their digital therapeutics platform, which has shown promising results in improving patient outcomes in bariatric care. The overall impact of TruMED lies in its ability to enhance patient-provider interactions and provide scalable, data-driven solutions to combat obesity, thereby contributing significantly to public health.
